Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Patients With High Probability of Not or Poorly Responding to Mycophenolate-mofetil (Cellcept®) or Mycophenolate-natrium (Myfortic®) Therapy

NCT00978965 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT00978965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00978965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Patients With High Probability of Not or Poorly Responding to Mycophenolate-mofetil (Cellcept®) or Mycophenolate-natrium (Myfortic®) Therapy
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
September 9, 2020
Enrollment
277 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplantation